Micronuclei in lymphocytes of children from the vicinity of Chernobyl before and after I-131 therapy for thyroid cancer

被引:38
作者
Wuttke, K
Streffer, C
Muller, WU
Reiners, C
Biko, J
Demidchik, E
机构
[1] UNIV ESSEN GESAMTHSCH KLINIKUM, INST MED STRAHLENBIOL, D-45122 ESSEN, GERMANY
[2] UNIV ESSEN GESAMTHSCH KLINIKUM, NUKL MED KLIN & POLIKLIN, D-45122 ESSEN, GERMANY
[3] CTR THYROID TUMORS, MINSK, BELARUS
关键词
D O I
10.1080/095530096146101
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The present study addresses the monitoring of children from the Belorussian and Ukrainian Republics exposed to the fall-out of the Chernobyl accident. Micronucleus analysis has been performed on 56 children from different areas. The micronucleus frequencies in individuals as well as in regional groups were comparable with controls, except for three donors. Such results had to be expected, taking into account that at least 7 years have passed since the accident. Most of the children whose micronucleus frequencies were determined are suffering from thyroid cancer and were treated by radioiodine (I-131) therapy. We studied the effect of in vitro exposure with I-131 on micronucleus induction and that proliferative ability of lymphocytes. The present investigation indicates that micronuclei can be usefully employed to detect individual exposures to the incorporated radionuclide within several days after the intake of the radionuclide in a dose range of around 65-390 mGy (effective dose).
引用
收藏
页码:259 / 268
页数:10
相关论文
共 50 条
  • [41] Dosimetry based high dose I-131 therapy for thyroid cancer
    Menda, Yusuf
    Madsen, Mark
    Bushnell, David
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [42] THYROID-CANCER - I-131 AND FERTILITY
    COUETTE, JE
    VAN, HL
    SWITSERS, O
    BRUNE, D
    LEMOUEL, M
    ROBILLARD, J
    JOURNAL DE BIOPHYSIQUE ET DE BIOMECANIQUE, 1987, 11 (03): : 134 - 134
  • [43] Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy
    Liang, Chunlan
    Wu, Changlin
    Liu, Lian
    Zhong, Jingxiang
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [44] TASTE LOSS AFTER I-131 TREATMENT FOR THYROID-CANCER
    VARMA, VM
    GROLLMAN, EF
    DAI, WL
    HENKIN, RI
    CLINICAL RESEARCH, 1992, 40 (02): : A417 - A417
  • [45] EVALUATION OF ROUTINE PERTECHNETATE THYROID IMAGING PRE I-131 THERAPY FOR THYROID CANCER
    Lee, S.
    Patel, M.
    Sheldon, J.
    Wilkinson, L.
    Yap, K.
    Taubman, K.
    Schlicht, S.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 41 - 41
  • [46] CANCER INCIDENCE AND MORTALITY AFTER I-131 THERAPY FOR HYPERTHYROIDISM
    HALL, P
    HOLM, LE
    RADIATION AND PUBLIC PERCEPTION: BENEFITS AND RISKS, 1995, 243 : 103 - 112
  • [47] ENHANCED TOTAL-BODY I-131 CLEARANCE AFTER I-131 ABLATIVE THERAPY FOR THYROID-CANCER WITH ORALLY-ADMINISTERED FUROSEMIDE
    SEABOLD, JE
    BENHAIM, S
    PETTIT, WA
    ROJESKI, MA
    GURLL, NJ
    PONTO, JA
    RADIOLOGY, 1992, 185 : 262 - 262
  • [48] Outpatient Therapeutic I-131 for Thyroid Cancer
    Panzegrau, Beata
    Gordon, Leonie
    Goudy, Glen H.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2005, 33 (01) : 28 - 30
  • [49] Pregnancy outcome after I-131 treatment for patients with thyroid cancer
    Ko, Kuan-Yin
    Kao, Chia-Hung
    Lin, Cheng-Li
    Yen, Ruoh-Fang
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] LEUKEMIA AFTER I-131 TREATMENT OF THYROID-CANCER - COMMENTS
    LARSSON, LG
    ACTA ONCOLOGICA, 1992, 31 (01) : 65 - 65